Press Releases
To stay up to date with our development, sign up for a subscription.
2020
2020-08-19 08:00
Device Technologies has over 850 employees supplying Australia and New Zealand with leading edge globally trusted brands within both medical devices and pharmaceuticals. “Device Technologies is a leading distributor in the region and AnaConDa makes...
2020-07-10 07:00
" We are proud to have conducted the world's largest study of inhaled sedation in intensive care. This is the most significant milestone in inhaled sedation since the development of the AnaConDa. The study confirms the clinical experience of...
2020-07-01 11:30
“All these distributors are leaders in their markets, and it is very gratifying that they will now launch our therapy. We put a lot of effort into the European market ourselves and appreciate the great interest that exists in launching and selling...
2020-06-25 08:00
“We highly appreciate the great interest there is in launching and selling AnaConDa in the markets we do not cover ourselves. Through this expansion of our distributor network, we are strengthening the position ahead of the upcoming market launch...
2020-05-20 16:30
"Through the incentive program, the senior management’s ownership in Sedana Medical has increased significantly, which is positive. The share sales made in connection with the exercise have mainly been made in order to finance the exercise...
2020-05-19 17:00
Adoption of the profit and loss statement and the balance sheet, the consolidated profit and loss statement and the consolidated balance sheet as well as resolution regarding allocation of profits and discharge from liability The general meeting adopted...
2020-05-15 10:00
As previously announced, Sedana Medical provides financial support to SESAR, a prospective, randomized and controlled study comparing inhaled sedation and intravenous sedation. The study is conducted in 30 different intensive care units in France and...
2020-05-12 09:00
The study, Inhaled Sedation in Covid-19-related Acute Respiratory Distress Syndrome, (ISCA), is planned to enroll a minimum of 400 patients and will be conducted in approximately 30 ICUs in France, Germany, Spain and Switzerland. The primary endpoint...
2020-05-07 07:00
Financial Summary January-March . Significant events during the period Significant events after the period Outlook 2020 CEO comments The first quarter of 2020 was largely marked by the covid-19 pandemic. With our treatment you can say that we are in the...
2020-04-22 08:00
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announce that its Annual Report for 2019 has been published and is available on http://www.sedanamedical.com under Investors.
For additional information, please contact:
Christer Ahlberg, vd, Sedana Medical...